Profil
Alan Naylor founded Pathios Therapeutics Ltd. in 2017, where he is working as Head-Drug Discovery from 2017.
Dr. Naylor also currently works at Brandon Capital Partners Pty Ltd., as Advisor from 2015.
Dr. Naylor received his graduate degree from the University of Liverpool Management School.
Aktive Positionen von Alan Naylor
| Unternehmen | Position | Beginn |
|---|---|---|
Pathios Therapeutics Ltd.
Pathios Therapeutics Ltd. BiotechnologyHealth Technology Engages in discovering and developing novel small molecule drugs | Gründer | 01.01.2017 |
Brandon Capital Partners Pty Ltd.
Brandon Capital Partners Pty Ltd. Investment ManagersFinance Brandon Capital Partners invests in companies located in the Australia and New Zealand. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Berater | 01.01.2015 |
Ausbildung von Alan Naylor
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Brandon Capital Partners Pty Ltd.
Brandon Capital Partners Pty Ltd. Investment ManagersFinance Brandon Capital Partners invests in companies located in the Australia and New Zealand. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Finance |
Pathios Therapeutics Ltd.
Pathios Therapeutics Ltd. BiotechnologyHealth Technology Engages in discovering and developing novel small molecule drugs | Health Technology |
University of Liverpool Management School
University of Liverpool Management School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















